Trial Profile
Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 08 Aug 2018
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary) ; Nortriptyline
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 18 Nov 2011 Actual end date changed from May 2010 to Nov 2011 as reported by ClinicalTrials.gov (NCT00539240).
- 25 May 2011 Planned end date changed from 1 May 2010 to 1 Aug 2011 as reported by ClinicalTrials.gov (NCT00539240).
- 10 May 2011 Results presented at Digestive Disease Week 2011.